Comparison of the efficacy between paclitaxel/carboplatin and doxorubicin/cisplatin for concurrent chemoradiation treatment in early stage high-risk and advanced endometrial cancer

被引：0
|
作者：
Kim, H.
Kim, J.
Chung, H.
Park, N.
Song, Y.
Kang, S.
Lee, H.
机构：
[1] Seoul Natl Univ Hosp, Seoul 110744, South Korea
[2] Konkuk Univ Hosp, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.16591
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
16591
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Comparison of the efficacy between paclitaxel/carboplatin and doxorubicin/cisplatin for concurrent chemoradiation in intermediate- or high-risk endometrioid endometrial cancer: A single institution experience
    Kim, Hee Seung
    Kim, Jae Weon
    Wu, Hong Gyun
    Chung, Hyun Hoon
    Park, Noh Hyun
    Song, Yong Sang
    Kang, Soon Beom
    Lee, Hyo Pyo
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2010, 36 (03) : 598 - 604
  • [2] Concomitant Paclitaxel Plus Carboplatin and Radiotherapy for High-Risk or Advanced Endometrial Cancer
    Wen, Qiang
    Shao, ZhuYan
    Yang, ZhengYan
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (04) : 685 - 689
  • [3] Concurrent chemoradiation with carboplatin for locally advanced cervical cancer at high-risk for developing cisplatin-induced renal dysfunction
    Lucely Cetina
    Alicia Garcia-Arias
    Maria de Jesus Uribe
    Alma Astorga
    Myrna Candelaria
    Aida Mota
    Roque Guadarrama
    Lesbia Rivera
    Jose Hinojosa
    Alfonso Dueñas-Gonzalez
    BMC Cancer, 7 (Suppl 1)
  • [4] Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: A retrospective study
    Sovak, Mika A.
    Hensley, Martee L.
    Dupont, Jakob
    Ishill, Nicole
    Alektiar, Kaled M.
    Abu-Rustum, Nadeem
    Barakat, Richard
    Chi, Dennis S.
    Sabbatini, Paul
    Spriggs, David R.
    Aghajanian, Carol
    GYNECOLOGIC ONCOLOGY, 2006, 103 (02) : 451 - 457
  • [5] Phase II Study of Consolidation Chemotherapy after Adjuvant or Primary Concurrent Chemoradiation Using Paclitaxel and Carboplatin to Treat High-Risk Early-Stage or Locally Advanced Cervical Cancer
    Kim, Hee Seung
    Kim, Mi-Kyung
    Kim, Hak Jae
    Han, Seung-Su
    Kim, Jae Weon
    CANCER RESEARCH AND TREATMENT, 2012, 44 (02): : 97 - 103
  • [6] Adjuvant concurrent chemoradiation followed by chemotherapy for high-risk endometrial cancer
    Ren, Yulan
    Huang, Xiaowei
    Shan, Boer
    Wu, Xiaohua
    Huang, Xiao
    Shi, Daren
    Wang, Huaying
    GYNECOLOGIC ONCOLOGY, 2016, 140 (01) : 58 - 63
  • [7] Efficacy of postoperative radiotherapy combined with taxol plus carboplatin chemotherapy regimens in the treatment of high-risk early-stage endometrial cancer
    Kang, Ting
    Liu, Ningning
    Sun, Xiaodong
    Liu, Min
    JOURNAL OF BUON, 2021, 26 (02): : 561 - 568
  • [8] ADJUVANT CHEMOTHERAPY WITH CISPLATIN, DOXORUBICIN, AND CYCLOPHOSPHAMIDE (PAC) FOR EARLY-STAGE HIGH-RISK ENDOMETRIAL CANCER - A PRELIMINARY-ANALYSIS
    STRINGER, CA
    GERSHENSON, DM
    BURKE, TW
    EDWARDS, CL
    GORDON, AN
    WHARTON, JT
    GYNECOLOGIC ONCOLOGY, 1990, 38 (03) : 305 - 308
  • [9] Comparison of carboplatin-paclitaxel to docetaxel-cisplatin-5-flurouracil induction chemotherapy followed by concurrent chemoradiation for locally advanced head and neck cancer
    Herman, Lauren C.
    Chen, Lucy
    Garnett, Alexandra
    Feldman, Lawrence E.
    Smith, Brett
    Weichselbaum, Ralph R.
    Spiotto, Michael T.
    ORAL ONCOLOGY, 2014, 50 (01) : 52 - 58
  • [10] Chemotherapy for high-risk early-stage endometrial cancer
    Kodama, Junichi
    Seki, Noriko
    Hiramatsu, Yuji
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2007, 19 (01) : 42 - 47
12345